Ying Qu Selected Research

Ying Qu Research Topics

Disease

55	Neoplasms (Cancer) 11/2022 - 11/2005
25	Stomach Neoplasms (Stomach Cancer) 01/2021 - 11/2005
18	Breast Neoplasms (Breast Cancer) 02/2021 - 05/2010
18	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2006
13	Fibrosis (Cirrhosis) 07/2022 - 01/2012
12	Liver Cirrhosis (Hepatic Cirrhosis) 07/2022 - 01/2012
8	Chronic Hepatitis B 07/2022 - 05/2013
6	Carcinogenesis 01/2015 - 11/2005
5	Multiple Myeloma 11/2022 - 06/2015
5	Inflammation (Inflammations) 01/2022 - 09/2013
4	Infections 01/2022 - 01/2014
4	Carcinoma (Carcinomatosis) 05/2009 - 09/2006
3	Disease Progression 01/2021 - 09/2013
3	Hepatocellular Carcinoma (Hepatoma) 11/2019 - 08/2011
3	Rheumatoid Arthritis 01/2019 - 06/2017
2	Sepsis (Septicemia) 01/2022 - 01/2022
2	Glioblastoma (Glioblastoma Multiforme) 03/2021 - 01/2021
2	Triple Negative Breast Neoplasms 01/2021 - 07/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 11/2011
2	Lymphatic Metastasis 01/2021 - 09/2006
2	Liver Diseases (Liver Disease) 10/2017 - 09/2013
2	Schizophrenia (Dementia Praecox) 10/2008 - 08/2008
2	Colorectal Neoplasms (Colorectal Cancer) 10/2006 - 05/2006
1	Idiopathic Pulmonary Fibrosis 07/2022
1	Neonatal Sepsis 01/2022
1	Bone Diseases (Bone Disease) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 12/2021 - 03/2006
13	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2012
11	Messenger RNA (mRNA)IBA 01/2020 - 11/2005
11	Biomarkers (Surrogate Marker)IBA 01/2017 - 09/2008
10	Pharmaceutical PreparationsIBA 06/2022 - 01/2015
6	Biological ProductsIBA 01/2022 - 01/2007
6	MicellesIBA 02/2021 - 05/2014
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 02/2015
5	Transcription Factors (Transcription Factor)IBA 01/2021 - 05/2010
5	Small Interfering RNA (siRNA)IBA 11/2019 - 08/2006
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 09/2013
4	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2011
4	AntioxidantsIBA 01/2022 - 12/2010
4	DNA (Deoxyribonucleic Acid)IBA 02/2016 - 03/2006
4	Polo-Like Kinase 1IBA 01/2007 - 01/2006
3	EnzymesIBA 01/2022 - 12/2010
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2022 - 01/2006
3	Therapeutic UsesIBA 12/2021 - 02/2017
3	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2021 - 01/2012
3	Phosphotransferases (Kinase)IBA 01/2021 - 01/2006
3	HydrogelsIBA 10/2020 - 01/2016
3	Histone Deacetylases (Histone Deacetylase)IBA 10/2020 - 01/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 06/2010
3	Peptides (Polypeptides)IBA 11/2016 - 09/2012
3	CateninsIBA 12/2015 - 04/2014
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2021
2	Estrogens (Estrogen)FDA Link 01/2022 - 07/2016
2	CytokinesIBA 01/2022 - 09/2020
2	Interleukin-8 (Interleukin 8)IBA 01/2022 - 09/2020
2	Disulfiram (Antabuse)FDA Link 03/2021 - 01/2021
2	Docetaxel (Taxotere)FDA Link 02/2021 - 11/2016
2	Estrogen ReceptorsIBA 01/2021 - 06/2010
2	Histone Deacetylase InhibitorsIBA 12/2020 - 01/2018
2	NF-kappa B (NF-kB)IBA 12/2019 - 01/2012
2	LigandsIBA 11/2019 - 10/2018
2	Methotrexate (Mexate)FDA LinkGeneric 02/2019 - 01/2019
2	methoxy poly(ethylene glycol-co-epsilon-caprolactone)IBA 02/2019 - 05/2014
2	NanogelsIBA 01/2019 - 11/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2018 - 08/2006
2	ErbB Receptors (EGF Receptor)IBA 10/2018 - 01/2016
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2018 - 11/2016
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 06/2017 - 11/2015
2	PolymersIBA 02/2017 - 01/2016
2	WD repeat containing planar cell polarity effectorIBA 01/2017 - 11/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2016 - 06/2010
2	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 12/2015 - 11/2014
2	Claudin-1IBA 01/2015 - 04/2014
2	Neutralizing AntibodiesIBA 01/2014 - 07/2013
2	S 27IBA 12/2013 - 06/2012
2	Ribosomal Proteins (Ribosomal Protein)IBA 12/2013 - 06/2012
2	CholesterolIBA 05/2013 - 08/2011
2	hydroxide ionIBA 12/2010 - 10/2009
2	Protein Isoforms (Isoforms)IBA 05/2009 - 02/2009
2	E-SelectinIBA 05/2009 - 02/2009
2	Kallikreins (Kallikrein)IBA 10/2006 - 05/2006
1	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 10/2022
1	hydronidoneIBA 07/2022
1	entecavir FDA Link 07/2022
1	pirfenidoneIBA 07/2022
1	ChemokinesIBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Pancreatic Elastase (Elastase)IBA 12/2021

Therapy/Procedure

20	Therapeutics 11/2022 - 11/2005
12	Drug Therapy (Chemotherapy) 02/2021 - 09/2006
5	Precision Medicine 08/2021 - 05/2010
4	Photothermal Therapy 02/2021 - 01/2014
3	Immunotherapy 06/2022 - 11/2005
2	Transplantation 12/2021 - 01/2011
2	Photochemotherapy (Photodynamic Therapy) 02/2021 - 11/2016
2	Injections 10/2020 - 02/2019
2	Lasers (Laser) 10/2008 - 09/2008
1	Aftercare (After-Treatment) 01/2022